Literature DB >> 2536304

Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes.

T Kiyosue1, M Arita.   

Abstract

We used the patch clamp technique to study the nature of the late sodium current in guinea pig ventricular myocytes. In a cell attached mode of single channel recording at room temperature (22-24 degrees C) two kinds of late (100 msec or more after beginning of the depolarizing pulse) sodium channel activities were recognized. One is isolated brief openings appearing once for about 120 depolarizations per channel (background type), while the other type is sustained openings with rapid interruptions (burst type) that occurred only once for 2,700 depolarizations per channel. The time constant obtained from the open time histogram of the burst type (1.05 msec) was about five times longer than that of background type (0.18 msec, measured at the potential 10 mV above the threshold). Magnitude of the late sodium current flowing through the entire surface of a myocyte was estimated with tetrodotoxin (60 microM), a specific inhibitor of sodium channels, in whole-cell clamp experiments. The steady tetrodotoxin-sensitive current of 12 to 50 pA was registered at -40 mV (26 +/- 14 pA, mean +/- SD, n = 5), in good agreement with the late sodium current calculated from the single channel recording. Tetrodotoxin produced small (congruent to 10%) but significant decreases in the action potential duration. These results suggest the presence of a small but significant late sodium current with slow inactivation kinetics and that this current probably plays a significant role in maintaining the action potential plateau and the duration in guinea pig ventricular myocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536304     DOI: 10.1161/01.res.64.2.389

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

1.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

2.  Na channels that remain open throughout the cardiac action potential plateau.

Authors:  Y M Liu; L J DeFelice; M Mazzanti
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

3.  Actions and mechanisms of action of novel analogues of sotalol on guinea-pig and rabbit ventricular cells.

Authors:  S P Connors; E W Gill; D A Terrar
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

4.  Electrophysiological effects of CRE-1087 in guinea-pig ventricular muscles.

Authors:  E Delpón; C Valenzuela; O Pérez; J Tamargo
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

5.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

Review 6.  Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload.

Authors:  D Noble; P J Noble
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

7.  From the Hodgkin-Huxley axon to the virtual heart.

Authors:  Denis Noble
Journal:  J Physiol       Date:  2006-10-05       Impact factor: 5.182

Review 8.  Late sodium current in failing heart: friend or foe?

Authors:  Victor A Maltsev; Albertas Undrovinas
Journal:  Prog Biophys Mol Biol       Date:  2007-08-10       Impact factor: 3.667

9.  Effects of lisinopril on electromechanical properties and membrane currents in guinea-pig cardiac preparations.

Authors:  C Valenzuela; O Pérez; O Casis; J Duarte; F Pérez-Vizcaino; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 10.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.